Clinical Trial Update: Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058) [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating the cholesterol-lowering effects of two marketed drugs in adults with elevated cholesterol; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Drug A (not disclosed)
• Drug B (not disclosed)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED